Tags : Silicon

M&A

Roivant to Acquire Silicon Therapeutics for ~$450M

Shots: Roivant to acquire Silicon for $450M in Roivant’s equity with additional potential regulatory and commercial milestones. The acquisition will strengthen Roivant’s AI capabilities for drug discovery The acquisition of Silicon will bolster Roivant’s targeted protein degradation platform that will be powered by VantAI’s ML techniques The integration of Silicon and VantAI will allow Roivant […]Read More